Application of a mortality risk score in a general population of patients with an implantable cardioverter defibrillator (ICD)

Heart

Volumn 100, Issue 6, 2014, Pages 487-491

  Schaer, Beat A ^a   Kühne, Michael S ^a   Blatter, David ^a   Osswald, Stefan ^a   Sticherling, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONGESTIVE CARDIOMYOPATHY; DISEASE REGISTRY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECONDARY PREVENTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; SUDDEN CARDIAC DEATH; VENTRICULAR FIBRILLATION; VENTRICULAR TACHYCARDIA;

AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SECONDARY PREVENTION; SURVIVAL RATE; SWITZERLAND; TACHYCARDIA, VENTRICULAR;

EID: 84896698352     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-305002     Document Type: Article

References (16)

1. Moss AJ, Hall WJ, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40. (Pubitemid 26428217)
2. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-90.
3. Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
4. Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
5. Koller MT, Schaer B, Wolbers M, et al. Death without prior appropriate ICD-therapy: a competing risk study of adequate therapy and death. Circulation 2008;117:1918-26. (Pubitemid 351543467)
6. Packer DL, Prutkin JM, Hellkamp AS, et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation 2009;120:2170-6.
7. Goldenberg I, Vyas AK, Hall WJ, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular function. J Am Coll Cardiol 2008;51:288-96.
8. Barsheshet A, Moss AJ, Huang DT, et al. Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator. J Am Coll Cardiol 2012;59:2075-9.
9. http://nephron.org/MDRD-GFR.cgi
10. Levey AS, Bosch JP, Breyer Lewis J, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70. (Pubitemid 29135798)
11. Buxton AE, Lee KL, Hafley GE, et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease. J Am Coll Cardiol 2007;50:1150-7. (Pubitemid 47375017)
12. Smith T, Levy WC, Schaer BA, et al. Performance of the Seattle Heart Failure Model in Implantable Defibrillator Patients Treated With Cardiac Resynchronization Therapy. Am J Cardiol 2012;110:398-402.
13. Regoli F, Scopigni F, Leyva F, et al. Validation of Seattle Heart Failure Model for mortality risk prediction in patients treated with cardiac resynchronization therapy. Eur J Heart Fail 2013;15:211-20.
14. Theuns DA, Schaer BA, Soliman OI, et al. The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality. Europace 2011;13:62-9.
15. Bhavnani SP, Coleman CI, Guertin D, et al. Evaluation of the Charlson comorbidity index to predict early mortality in implantable cardioverter defibrillator patients. Ann Noninvasive Electrocardiol 2013;18:379-88.
16. Soliman OI, Theuns DA, van Dalen BM, et al. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy. Am J Cardiol 2010;105:105-11.